Oral versus Gel formulation of drug Tamoxifen in Cyclical Breast pai
Phase 2
- Conditions
- Health Condition 1: E349- Endocrine disorder, unspecified
- Registration Number
- CTRI/2018/09/015845
- Lead Sponsor
- Dr Divya Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pre-menopausal women of or above 18 yrs of age having cyclical mastalgia for a period of 4 months or more who have completed their families
Exclusion Criteria
Adult women having pain in the breast due to a diagnosed and medically predetermined cause for example ca breast and extramammary pain costochondritis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method